The deubiquitinase USP44 enhances cisplatin chemosensitivity through stabilizing STUB1 to promote LRPPRC degradation in neuroblastoma
Neuro-Oncology · 2025
DOI: 10.1093/neuonc/noae175 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neuro-Oncology, 2025. Verfasst von Liang Zeng und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangdong Provincial Clinical Research Center f…. Hauptthemen laut MEDLINE: Neuroblastoma, Cisplatin, Ubiquitin Thiolesterase, Ubiquitin-Protein Ligases. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: the National Natural Science Foundation of China, the Department of Science and Technology of Guangdong Province, Guangzhou Women and Children's Medical Center.
Abstract (Originalsprache)
Background
Dysregulated deubiquitinating enzymes (DUBs) execute as intrinsic oncogenes or tumor suppressors and are involved in chemoresistance in cancers. However, the functions and exact molecular mechanisms remain largely unclear in neuroblastoma.
Methods
Here, an R2 screening strategy based on the standard deviation values was used to identify the most important DUB, USP44, in neuroblastoma with stage 4. We validated the role of USP44 regulation upon cisplatin treatment in vitro and in vivo experiments, revealing the molecular mechanisms associated with USP44 regulation and cisplatin sensitivity in neuroblastoma.
Results
We found that low USP44 expression was associated with an inferior prognosis in neuroblastoma patients. Overexpression of USP44 enhanced neuroblastoma cell sensitivity to cisplatin in vitro and in vivo. Mechanistically, USP44 recruited and stabilized the E3 ubiquitin ligase STUB1 by removing its K48-linked polyubiquitin chains at Lys30, and STUB1 further reinforced the K48-linked polyubiquitination of LRPPRC at Lys453 and promoted its protein degradation, thus enhancing the accumulation of mitochondrial reactive oxygen species (mROS), in turn facilitating neuroblastoma cell apoptosis and cisplatin sensitivity. Additionally, overexpression of LRPPRC reversed the promoting effect of USP44 on cell apoptosis in cisplatin-treated neuroblastoma cells.
Conclusions
Our findings demonstrate that the USP44–STUB1–LRPPRC axis plays a pivotal role in neuroblastoma chemoresistance and provides potential targets for neuroblastoma therapy and prognostication.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangdong Provincial Clinical Research Center for Child Health, National Children's Medical Center for South Central…
- Department of Experimental Research, State Key Laboratory of Oncology in Southern China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, P. R. China.
- Guangdong Provincial Key Laboratory of Research in Structure Birth Defect Disease, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, P. R. China.
- Department of Breast and Thyroid Surgery, The Second Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, P. R. China.
- Department of Thoracic Surgery, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangdong Provincial Clinical Research Center for Child Health, National Children's Medical Center for South C…
- Guangzhou Institute of Paediatrics, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, National Children's Medical Center for South Central Region, Guangzhou, P. R. China.
ORCID-Profile: Na Liu, Hai-Yun Wang
Förderung
- the National Natural Science Foundation of China
- the Department of Science and Technology of Guangdong Province
- Guangzhou Women and Children's Medical Center
- Guangzhou Women and Children’s Medical Center
Zitieren
APA
Zeng, L., Li, Y. Q., He, S. W., Xu, H., Zhang, R., Chen, K., Qin, L. J., Zhu, X. H., Li, Y. L., Li, L., Liu, N., & Wang, H. Y. (2025). The deubiquitinase USP44 enhances cisplatin chemosensitivity through stabilizing STUB1 to promote LRPPRC degradation in neuroblastoma. Neuro-Oncology. https://doi.org/10.1093/neuonc/noae175
Vancouver
Zeng L, Li YQ, He SW, Xu H, Zhang R, Chen K, et al. The deubiquitinase USP44 enhances cisplatin chemosensitivity through stabilizing STUB1 to promote LRPPRC degradation in neuroblastoma. Neuro-Oncology. 2025. doi:10.1093/neuonc/noae175
BibTeX
@article{Zeng2025,
author = {Zeng, Liang and Li, Ying-Qing and He, Shi-Wei and Xu, Hui and Zhang, Ruizhong and Chen, Kai and Qin, Liang-Jun and Zhu, Xun-Hua and Li, Yi-Lin and Li, Le and Liu, Na and Wang, Hai-Yun},
title = {The deubiquitinase USP44 enhances cisplatin chemosensitivity through stabilizing STUB1 to promote LRPPRC degradation in neuroblastoma},
journal = {Neuro-Oncology},
year = {2025},
doi = {10.1093/neuonc/noae175}
}
EUVIMED